COMMUNIQUÉS West-GlobeNewswire

-
Communiqué de presse : Le Dupixent devient le premier nouveau médicament ciblé approuvé aux États-Unis depuis plus de dix ans pour le traitement de l’urticaire chronique spontanée
18/04/2025 -
PrimeBiome Reviews: MUST READ - Shocking Results - Ingredients & It's Benefits
18/04/2025 -
Healthcare Integrated Technologies Inc. Appoints Theo Davies as Chief Revenue Officer
18/04/2025 -
Lipozem Legal Alternatives: 2025 User Discover the Biggest Complaints
18/04/2025 -
Dipharma Awarded Bronze Medal by Ecovadis for Sustainability
18/04/2025 -
Communiqué de presse - Sanofi inaugure en France sa nouvelle unité d’excellence R&D Vaccins
18/04/2025 -
Jushi Holdings Inc. Announces Grand Opening of Beyond Hello™ Mansfield in Ohio, Expanding Its Statewide Retail Footprint
18/04/2025 -
Madrigal Pharmaceuticals to Release First-Quarter 2025 Financial Results and Host Webcast on May 1, 2025
18/04/2025 -
Best Legal Steroids 2025: Natural Alternatives That Work For Bulking, Cutting & Muscle Growth By CrazyBulk
18/04/2025 -
Best Steroids for Women - Anabolic Steroids For Female Bodybuilders for Weight Loss & Muscle Gain By CrazyBulk
18/04/2025 -
Best Testosterone Booster for Muscle Gain and Erectile Dysfunction - Top OTC Testosterone Supplements for Men Over 40 (By TestoPrime)
18/04/2025 -
Prime Biome Reviews And Complaints (EXPOSED) Consumers Reveal Unexpected Truths Behind Its Effectiveness & Safety!
18/04/2025 -
Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers
18/04/2025 -
Valneva fait le point sur la recommandation de l'ACIP pour les voyageurs américains concernant son vaccin IXCHIQ® contre le chikungunya
18/04/2025 -
XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
18/04/2025 -
Sotera Health Announces First-Quarter 2025 Earnings Release Date
17/04/2025 -
Pacira BioSciences Reaffirms Commitment to Enhancing Value for All Shareholders
17/04/2025 -
FOXO TECHNOLOGIES INC. ANNOUNCES REVERSE STOCK SPLIT
17/04/2025 -
Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/04/2025
Pages